In this captivating interview from ISHI 34, we sit down with Melissa, a seasoned forensic science professional from QIAGEN, who shares her journey from being a student presenter at her first ISHI to her current role amidst QIAGEN’s recent acquisition of Verogen. With a career that transitioned from hands-on lab work to influencing product development, Melissa provides a unique perspective on the evolution of forensic science, especially the integration of Next Generation Sequencing (NGS) into forensic workflows.
Melissa delves into QIAGEN’s comprehensive offerings that now span the entire forensic workflow, thanks to the strategic acquisition of Verogen. This merger not only broadens QIAGEN’s capabilities in the NGS space but also establishes the company as a one-stop shop for forensic laboratories seeking to expand their genetic analysis tools. She highlights the significance of NGS in forensic science, offering laboratories the ability to extract more information from limited samples and emphasizing the importance of kits like the NDIS-approved MainstAY and the innovative Kintelligence, which are transforming forensic investigations.
Join us as we explore the past, present, and future of forensic science with one of the field’s most passionate advocates, and discover why ISHI remains an unmissable event for professionals dedicated to making a difference through DNA analysis.
